Life-long health consequences of undernutrition in the Yanomami indigenous population in Brazil.

Correspondence from Thiago dos Reis Araujo, Ana Paula Davel and Everardo Magalhães Carneiro unicampoficial

nature.com/articles/s4159…

An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution.

Comment from Lorenzo Subissi Maria Van Kerkhove and colleagues World Health Organization (WHO)

nature.com/articles/s4159…

The argument framework is a flexible approach to evidence in healthcare.

Comment from Jonathan Fuller, Benjamin Chin-Yee and Ross E. G. Upshur

nature.com/articles/s4159…

Adequate information about clinical trial results must be given to participants.

Comment from Rafael Dal-Ré and colleagues UAM Autónoma Madrid

nature.com/articles/s4159…

Our #Oncology editor Ulrike Harjes will be attending #ESMOBreast24 , reach out to her if you would like to meet!

The future of brain–computer interfaces in medicine.

Read our latest Clinical Pipeline column, by Paul Webster.

nature.com/articles/d4159…

⭐Research highlight: Enzymes derived from gut bacteria switch A and B blood types to Group O (‘universal’), a strategy that could help solve blood donor shortages in the future. Nature Microbiology
nature.com/articles/d4159…

Refining #neoadjuvant #immunotherapy for resectable #NSCLC : Perioperative approaches are expanding, and new data show feasibility of co-targeting PD-1 and LAG-3.
News and Views from Christine Lovly, MD, PhD and Misty Dawn Shields Vanderbilt University Medical Center
nature.com/articles/s4159…

#AI in #Surgery : Our latest review outlines the ‘state of the art’ of AI in the preoperative, intraoperative & postoperative settings, and the potential for improving outcomes, education, & system efficiencies.
Eric Topol Greg O'Grady Prof Ewen Harrison
nature.com/articles/s4159…

At Biao Zheng's talk #ASGCT24 Cell-Based Gene Therapy Trials session? Take a look at this clinical report of CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia nature.com/articles/s4159…

⭐Research highlight: Final results of two studies — whose preliminary data led to regulatory approval of the #genetherapy exagamglogene autotemcel — describe highly effective treatment of sickle-cell disease and transfusion-dependent β-thalassemia. NEJM
nature.com/articles/d4159…

Strategies for controlling pneumococcal disease and outbreaks during humanitarian emergencies.

Correspondence from Brenda Kwambana-Adams and colleagues.

nature.com/articles/s4159…

Urgent action is needed to confront artemisinin partial resistance in African malaria parasites.

Correspondence from Abdoulaye DJIMDE The Fidock Lab and colleagues.

nature.com/articles/d4159…

At #ASGCT24 In Vivo Gene Therapy Clinical Trials session? Take a look at this clinical report of AAV gene therapy for Tay-Sachs disease from speaker Terry Flotte UMass Chan Medical School
nature.com/articles/s4159…

Reproductive rights in the United States: acquiescence is not a strategy.

Comment from Dr. Laura Esserman & Douglas Yee MD, as part of our ongoing series on Women's Health

nature.com/articles/s4159…

Climate change and health: understanding mechanisms will inform mitigation and prevention strategies.

Comment from Robbie M. Parks and colleagues Columbia University

nature.com/articles/s4159…

Adequate information about clinical trial results must be given to participants.

Comment from Rafael Dal-Ré and colleagues UAM Autónoma Madrid

nature.com/articles/s4159…

The argument framework is a flexible approach to evidence in healthcare.

Comment from Jonathan Fuller, Benjamin Chin-Yee and Ross E. G. Upshur

nature.com/articles/s4159…

Life-long health consequences of undernutrition in the Yanomami indigenous population in Brazil.

Correspondence from Thiago dos Reis Araujo, Ana Paula Davel and Everardo Magalhães Carneiro unicampoficial

nature.com/articles/s4159…

At #ASGCT24 Presidential symposium? Take a look at the recent study on the long-term and real-world safety and efficacy of retroviral #GeneTherapy for adenosine deaminase deficiency, from speaker Alessandro Aiuti Ospedale San Raffaele nature.com/articles/s4159…